Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at La Jolla, California and other locations
Dates
study started
completion around
Principal Investigator
by Lyudmila A. Bazhenova
Headshot of Lyudmila A. Bazhenova
Lyudmila A. Bazhenova

Description

Summary

This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.

Official Title

Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)

Details

Keywords

Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage II Lung Non-Small Cell Cancer AJCC v7, Stage IIA Lung Cancer AJCC v8, Stage IIB Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8, Stage IIIA Lung Non-Small Cell Cancer AJCC v7, Stage IIIB Lung Cancer AJCC v8, Lung Neoplasms, Non-Small-Cell Lung Carcinoma, Paclitaxel, Cisplatin, Carboplatin, Gemcitabine, Pembrolizumab, Nivolumab, Pemetrexed, Albumin-Bound Paclitaxel, Crizotinib, Tyrosine Kinase Inhibitors, Biospecimen Collection, Clinical Observation, Computed Tomography, Cytology Specimen Collection Procedure, Echocardiography, Erlotinib, Gemcitabine Hydrochloride, Pemetrexed Disodium, Positron Emission Tomography

Eligibility

Locations

Lead Scientist at UCSD

  • Lyudmila A. Bazhenova
    Dr. Bazhenova’s clinical practice and research concentrate on lung cancer, particularly as this relates to females and non-smokers. She actively participates in cooperative group trials, and takes an active role in designing and implementing clinical investigations, including phase II studies and correlative science projects with several UCSD investigators.

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
National Cancer Institute (NCI)
ID
NCT02194738
Study Type
Interventional
Participants
Expecting 8300 study participants
Last Updated